242 related articles for article (PubMed ID: 18838537)
1. Decreased recognition of SUMO-sensitive target genes following modification of SF-1 (NR5A1).
Campbell LA; Faivre EJ; Show MD; Ingraham JG; Flinders J; Gross JD; Ingraham HA
Mol Cell Biol; 2008 Dec; 28(24):7476-86. PubMed ID: 18838537
[TBL] [Abstract][Full Text] [Related]
2. Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9.
Komatsu T; Mizusaki H; Mukai T; Ogawa H; Baba D; Shirakawa M; Hatakeyama S; Nakayama KI; Yamamoto H; Kikuchi A; Morohashi K
Mol Endocrinol; 2004 Oct; 18(10):2451-62. PubMed ID: 15192080
[TBL] [Abstract][Full Text] [Related]
3. The DEAD-box protein DP103 (Ddx20 or Gemin-3) represses orphan nuclear receptor activity via SUMO modification.
Lee MB; Lebedeva LA; Suzawa M; Wadekar SA; Desclozeaux M; Ingraham HA
Mol Cell Biol; 2005 Mar; 25(5):1879-90. PubMed ID: 15713642
[TBL] [Abstract][Full Text] [Related]
4. SUMOylation inhibits SF-1 activity by reducing CDK7-mediated serine 203 phosphorylation.
Yang WH; Heaton JH; Brevig H; Mukherjee S; Iñiguez-Lluhí JA; Hammer GD
Mol Cell Biol; 2009 Feb; 29(3):613-25. PubMed ID: 19015234
[TBL] [Abstract][Full Text] [Related]
5. Transcription regulation of nuclear receptor PXR: Role of SUMO-1 modification and NDSM in receptor function.
Priyanka ; Kotiya D; Rana M; Subbarao N; Puri N; Tyagi RK
Mol Cell Endocrinol; 2016 Jan; 420():194-207. PubMed ID: 26549688
[TBL] [Abstract][Full Text] [Related]
6. Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation.
Saito Â; Souza EE; Costa FC; Meirelles GV; Gonçalves KA; Santos MT; Bressan GC; McComb ME; Costello CE; Whelan SA; Kobarg J
J Proteome Res; 2017 Sep; 16(9):3147-3157. PubMed ID: 28695742
[TBL] [Abstract][Full Text] [Related]
7. The transcriptional repression activity of KyoT2 on the Notch/RBP-J pathway is regulated by PIAS1-catalyzed SUMOylation.
Wang J; Qin H; Liang J; Zhu Y; Liang L; Zheng M; Han H
J Mol Biol; 2007 Jun; 370(1):27-38. PubMed ID: 17509614
[TBL] [Abstract][Full Text] [Related]
8. Coactivation of SF-1-mediated transcription of steroidogenic enzymes by Ubc9 and PIAS1.
Suda N; Shibata H; Kurihara I; Ikeda Y; Kobayashi S; Yokota K; Murai-Takeda A; Nakagawa K; Oya M; Murai M; Rainey WE; Saruta T; Itoh H
Endocrinology; 2011 Jun; 152(6):2266-77. PubMed ID: 21467194
[TBL] [Abstract][Full Text] [Related]
9. System-wide Analysis of SUMOylation Dynamics in Response to Replication Stress Reveals Novel Small Ubiquitin-like Modified Target Proteins and Acceptor Lysines Relevant for Genome Stability.
Xiao Z; Chang JG; Hendriks IA; Sigurðsson JO; Olsen JV; Vertegaal AC
Mol Cell Proteomics; 2015 May; 14(5):1419-34. PubMed ID: 25755297
[TBL] [Abstract][Full Text] [Related]
10. Modification of cardiac transcription factor Gata6 by SUMO.
Chen H; Sun W; Zhu J; Yuan H; Chu M; Wen B
Biochimie; 2020 Mar; 170():212-218. PubMed ID: 32017966
[TBL] [Abstract][Full Text] [Related]
11. Sumoylation differentially regulates Goosecoid-mediated transcriptional repression.
Izzi L; Narimatsu M; Attisano L
Exp Cell Res; 2008 Apr; 314(7):1585-94. PubMed ID: 18336814
[TBL] [Abstract][Full Text] [Related]
12. Site-specific identification of SUMO-2 targets in cells reveals an inverted SUMOylation motif and a hydrophobic cluster SUMOylation motif.
Matic I; Schimmel J; Hendriks IA; van Santen MA; van de Rijke F; van Dam H; Gnad F; Mann M; Vertegaal AC
Mol Cell; 2010 Aug; 39(4):641-52. PubMed ID: 20797634
[TBL] [Abstract][Full Text] [Related]
13. The transactivation function of the Pea3 subfamily Ets transcription factors is regulated by sumoylation.
Bojović BB; Hassell JA
DNA Cell Biol; 2008 Jun; 27(6):289-305. PubMed ID: 18447755
[TBL] [Abstract][Full Text] [Related]
14. SUMO-mediated inhibition of glucocorticoid receptor synergistic activity depends on stable assembly at the promoter but not on DAXX.
Holmstrom SR; Chupreta S; So AY; Iñiguez-Lluhí JA
Mol Endocrinol; 2008 Sep; 22(9):2061-75. PubMed ID: 18562626
[TBL] [Abstract][Full Text] [Related]
15. Steroidogenic factor 1-dependent promoter activity of the human steroidogenic acute regulatory protein (StAR) gene.
Sugawara T; Holt JA; Kiriakidou M; Strauss JF
Biochemistry; 1996 Jul; 35(28):9052-9. PubMed ID: 8703908
[TBL] [Abstract][Full Text] [Related]
16. Eliminating SF-1 (NR5A1) sumoylation in vivo results in ectopic hedgehog signaling and disruption of endocrine development.
Lee FY; Faivre EJ; Suzawa M; Lontok E; Ebert D; Cai F; Belsham DD; Ingraham HA
Dev Cell; 2011 Aug; 21(2):315-27. PubMed ID: 21820362
[TBL] [Abstract][Full Text] [Related]
17. Pax8 protein stability is controlled by sumoylation.
de Cristofaro T; Mascia A; Pappalardo A; D'Andrea B; Nitsch L; Zannini M
J Mol Endocrinol; 2009 Jan; 42(1):35-46. PubMed ID: 18974227
[TBL] [Abstract][Full Text] [Related]
18. Dynamic sumoylation of promoter-bound general transcription factors facilitates transcription by RNA polymerase II.
Baig MS; Dou Y; Bergey BG; Bahar R; Burgener JM; Moallem M; McNeil JB; Akhter A; Burke GL; Sri Theivakadadcham VS; Richard P; D'Amours D; Rosonina E
PLoS Genet; 2021 Sep; 17(9):e1009828. PubMed ID: 34587155
[TBL] [Abstract][Full Text] [Related]
19. The putative nuclear localization signal of the human RAD52 protein is a potential sumoylation site.
Saito K; Kagawa W; Suzuki T; Suzuki H; Yokoyama S; Saitoh H; Tashiro S; Dohmae N; Kurumizaka H
J Biochem; 2010 Jun; 147(6):833-42. PubMed ID: 20190268
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.
Bossis G; Malnou CE; Farras R; Andermarcher E; Hipskind R; Rodriguez M; Schmidt D; Muller S; Jariel-Encontre I; Piechaczyk M
Mol Cell Biol; 2005 Aug; 25(16):6964-79. PubMed ID: 16055710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
